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Background and Aims: The aim of this study was to elucidate the roles of 
microRNA deregulations in colorectal cancer (CRC) development.  
Methods: Expression levels of 95 human mature microRNAs (miRNAs) were 
examined using real-time PCR based expression arrays on 10 paired colorectal 
carcinomas and normal tissues. Down-regulation of miR-143 was further evaluated in 
colon cancer cell lines and 30 paired CRC and normal tissues by quantitative PCR. 
Potential targets of miR-143 were defined. The functional effect of the miR-143 and 
its targets was performed in human colon cancer cell lines to confirm target 
association.  
Results: We identified the most 10 down-regulated miRNAs in CRC including 
miR-30a-5p, miR-145, miR-137, miR-133a, miR-204, miR-143, miR-215, miR-26a, 
miR-125b, miR-125a. Down-regulation of miR-143 was further verified in both seven 
human colon cancer cell lines and 90% (27/30) of CRC tissues (P < 0.0001). Using 
in-silico predictions, DNMT3a was defined as a downstream potential target of 
miR-143. Restoration of miR-143 expression in colon cancer cell lines 
down-regulated expression of DNMT3a, decreased tumor cell growth by MTT assay 
(P < 0.05) and soft agar colony formation assay (P < 0.05). Expressions of DNMT3a 
and miR-143 were inversely correlated in CRC tissues. DNMT3a was further 
demonstrated to be a direct target of miR-143 by luciferase reporter activity assay. 
Conclusions: Our findings demonstrated that down-regulation of miR-143 and 
up-regulation of DNMT3a are significant changes in the development of CRC. These 
findings point to a tumor suppressive role of miR-143 in epigenetic aberration of CRC, 
pointing to miRNA-based targeted approaches for colorectal cancer therapy. 
  
 
